PM360

SEPTEMBER 21, 2023

As many in the industry now know, the Inflation Reduction Act (IRA) is the most significant reform of Medicare prescription drug coverage since the creation of Part D and has wide-ranging implications for the healthcare industry. After this period, CMS will begin to include physician-administered drugs covered under Part B in the program.

Manufacturing 111

Manufacturing Marketing Competition Physicians 111

PM360

MAY 21, 2024

beatriz.gonzalez@teads.com BEATRIZ GONZÁLEZ CASAURRÁN Senior Global Industry Director CPG at Teads In healthcare, streaming platforms, Connected TV (CTV), and omnichannel strategies are offering a myriad of new, efficient, and effective advertising opportunities.

Media 105

Media Healthcare Healthcare Marketing 105

PM360

DECEMBER 14, 2022

In its latest venture into the healthcare arena, Amazon is reaching out directly to the consumer via its soon-to-be-launched Amazon Clinic , a virtual health service for patients to see licensed clinicians about common medical issues. billion euros into its new facility where it is planning to hire 400 and 500 new personal by 2027.

Manufacturing 52

Manufacturing Medical Healthcare Healthcare 52

PM360

APRIL 7, 2023

Most immediately, it will add confusion in the healthcare space,” explains Daniel Sontupe, Associate Partner, Managing Director, The Bloc Value Builders. This will create confusion in the marketplace and may possibly lead to delivery of misinformation to healthcare providers (HCPs) regarding a brand’s drug coverage,” Bambalas says.

Marketing 52

Marketing Pharma Manufacturing Healthcare 52

PM360

JUNE 29, 2022

Healthcare and pharma companies are watching this trend and refining their strategies to meet tomorrow’s health consumer. What if you scan a QR code on the box or bottle and it would trigger an approval from your healthcare provider? Walmart has recently focused on expanding its virtual healthcare presence.

Retail 97

Retail Marketing Healthcare Healthcare 97

Clarivate

SEPTEMBER 5, 2024

1: CMS obtained steep price cuts in its first round of negotiations Source: The Centers for Medicare & Medicaid Services By 2027, 20 additional drugs per year will be negotiated, including often complex and expensive physician-administered Medicare Part B drugs, such as infusible biologics.

Insurance 52

Insurance Marketing Manufacturing Prescription 52

PM360

SEPTEMBER 21, 2023

As a mission-driven company and digital healthcare leader, GoodRx has helped patients obtain an estimated 80 million prescriptions they otherwise may not have been able to afford. 1 We have been improving patient affordability for over a decade, across generic and brand medications, including specialty treatments—sometimes by more than 50%.

Prescription 52

Prescription Medical Patients Distribution 52

Clarivate

AUGUST 27, 2024

Increased appeal for dual-energy systems: Sometimes a situation calls for RF, but physicians like the ease and efficiency of PFA. With the global atrial fibrillation market at $6 billion today, that rate of growth would push it to $12 billion by mid-2027, if not sooner, with PFA accounting for about 70% of the market.

Marketing 52

Marketing Competition FDA Electronics 52

European Pharmaceutical Review

MARCH 4, 2024

percent through 2027. 12 Administration of biologics: key considerations Bio-drug delivery systems are linked to the route of administration in clinics, which must be taken into consideration in clinical development, given the growing emphasis on patient-centric healthcare delivery. References 1.

Food and Drug Administration 98

Food and Drug Administration Transportation FDA Medical 98

Evolve Your Success

OCTOBER 31, 2023

The perfect blend of persistent dedication, a heartwarming touch of southern hospitality, and an innate understanding of the needs of both physicians and patients. Tune in and discover how one individual’s dedication can truly make a difference in the world of healthcare. We assist with training the physicians.

Engineering 52

Engineering Sales Medical sales Medical 52

Clarivate

AUGUST 20, 2024

In 2025, CMS will select another 15 Part D drugs for negotiations that will take effect in 2027. CMS is targeting those therapies with the greatest Medicare spending, although therapies meeting certain criteria (e.g.,

Manufacturing 52

Manufacturing Government Prescription Pharmaceutical manufacturing 52

World of DTC Marketing

APRIL 12, 2022

healthcare system is bedeviled by greed, with drug companies, device manufacturers, hospital organizations, physician groups, and insurers scrambling to grab a slice of the more than $3 trillion we spend on medical care each year. The bifurcation within our healthcare system is poised to get worse. (FT.COM) The U.S.

Healthcare 209

Healthcare Healthcare Insurance Physicians 209

World of DTC Marketing

JULY 28, 2022

Late last year, the Senate Finance Committee released draft legislation enabling Medicare negotiation for up to 10 drugs in 2025, 15 in 2026 and 2027, and 20 in 2028 and beyond. This would include drugs covered by both Medicare Part B (physician-administered drugs) and Part D (prescription medications). The secretary of the U.S.

Pharma 256

Pharma Prescription Pharmaceutical Manufacturing 256